Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain

By Pan Hongming  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 259-267

Adis International

Access to resources Recommend Favorite

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study

By Wild John M.  

CNS Drugs, Vol. 23, Iss. 11, 2009-11 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension: An Open-Label, Long-Term Study

By Volpe Massimo   Miele Cristina  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 381-391

Adis International

Access to resources Recommend Favorite

Use of Recombinant Human Parathyroid Hormone(1-84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain - the PROPOSE Study

By Möricke Rüdiger  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial

By Hamilton Tiffani  

Drug Safety, Vol. 31, Iss. 8, 2008-01 ,pp. : 715-726

Adis International

Access to resources Recommend Favorite